A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: Rethinking the Gynecologic Oncology Group criteria

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 147, Issue 1, 2009, Pages 91-96

  Chang, Suk Joon ^a   Kim, Woo Young ^a   Yoo, Seung Chul ^a   Yoon, Jong Hyuck ^a   Chun, Mison ^a   Chang, Ki Hong ^a   Ryu, Hee Sug ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adjuvant radiation therapy; Cervical cancer; Intermediate risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURGICAL RISK; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 71749085026     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.07.013     Document Type: Article

References (20)

1. Samlal R.A., van der Velden J., Ten Kate F.J., Schilthuis M.S., Hart A.A., and Lammes F.B. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer 80 (1997) 1234-1240
2. Schorge J.O., Molpus K.L., Koelliker D., Nikrui N., Goodman A., and Fuller Jr. A.F. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 66 (1997) 31-35
3. Curtin J.P., Hoskins W.J., Venkatraman E.S., et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 61 (1996) 3-10
4. Delgado G., Bundy B.N., Fowler Jr. W.C., et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 35 (1989) 314-320
5. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38 (1990) 352-357
6. Bidus M.A., and Elkas J.C. Cervical and vaginal cancer. In: Berek J.S. (Ed). Berek & Novak's gynecology. 14th ed. (2007), Lippincott Williams & Wilkin, Philadelphia 1403-1456
7. Lai C.H., Chang H.C., Chang T.C., Hsueh S., and Tang S.G. Prognostic factors and impacts of adjuvant therapy in early stage cervical carcinoma with pelvic node metastases. Gynecol Oncol 51 (1993) 390-396
8. Sevin B.U., Lu Y., Bloch D.A., Nadji M., Koechli O.R., and Averette H.E. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78 (1996) 1438-1446
9. Hart K., Han I., Deppe G., et al. Postoperative radiation for cervical cancer with pathologic risk factors. Int J Radiat Oncol Biol Phys 37 (1997) 833-838
10. Tsai C.S., Lai C.H., Wang C.C., et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 75 (1999) 328-333
11. Peters III W.A., Liu P.Y., Barrett Jr. R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
12. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., and Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73 (1999) 177-183
13. Rotman M., Sedlis A., Piedmonte M.R., et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65 (2006) 169-176
14. Aoki Y., Watanabe M., Sasaki M., et al. Prognostic factors and failure pattern in lymph node-negative stage IB and II cervical carcinoma treated with radical hysterectomy and postoperative irradiation. Gynecol Obstet Invest 52 (2001) 13-17
15. Chen S.W., Liang J.A., Yang S.N., and Lin F.J. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy. Eur J Gynaecol Oncol 25 (2004) 81-86
16. Ayhan A., Al R.A., Baykal C., Demirtas E., Ayhan A., and Yüce K. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer 14 (2004) 286-292
17. Kodaira T., Fuwa N., Nakanishi T., et al. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease. Jpn J Clin Oncol 32 (2002) 255-261
18. Van de Putte G., Lie A.K., Vach W., Baekelandt M., and Kristensen G.B. Risk grouping in stage IB squamous cell cervical carcinoma. Gynecol Oncol 99 (2005) 106-112
19. Kridelka F.J., Berg D.O., Neuman M., et al. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Cancer 86 (1999) 2059-2065
20. Havrilesky L.J., Leath C.A., Huh W., et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol 93 (2004) 429-434